Combined genetic mutations and DNA-methylated genes as biomarkers for endometrial cancer detection from cervical scrapings
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-7083
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Combined genetic mutations and DNA-methylated genes as biomarkers for endometrial cancer detection from cervical scrapings ; volume:11 ; number:1 ; day:28 ; month:11 ; year:2019 ; pages:1-10 ; date:12.2019
Clinical epigenetics ; 11, Heft 1 (28.11.2019), 1-10, 12.2019
- Creator
-
Liew, Phui-Ly
Huang, Rui-Lan
Wu, Tzu-I
Liao, Chi-Chun
Chen, Chien-Wen
Su, Po-Hsuan
Wang, Hui-Chen
Weng, Yu-Chun
Lai, Hung-Cheng
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13148-019-0765-3
- URN
-
urn:nbn:de:101:1-2020032322464083989781
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Liew, Phui-Ly
- Huang, Rui-Lan
- Wu, Tzu-I
- Liao, Chi-Chun
- Chen, Chien-Wen
- Su, Po-Hsuan
- Wang, Hui-Chen
- Weng, Yu-Chun
- Lai, Hung-Cheng
- SpringerLink (Online service)
Other Objects (12)
Imaging of endometrial and cervical cancer
Innovations in Cervical and Endometrial Cancer
Potential new biomarkers for endometrial cancer
Methylated DNA/RNA in Body Fluids as Biomarkers for Lung Cancer
Endometrial carcinomas with ambiguous histology often harbor TP53 mutations
Identification of differentially methylated genes as diagnostic and prognostic biomarkers of breast cancer
Fertility preservation in women with cervical, endometrial or ovarian cancers
Endometrial polyps are non-neoplastic but harbor epithelial mutations in endometrial cancer drivers at low allelic frequencies
Protein biomarkers in cervicovaginal lavages for detection of endometrial cancer
Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells
JAK2 inactivating mutations promotes endometrial cancer progression by targeting HIF-1α
Effects of DNMT1 silencing on malignant phenotype and methylated gene expression in cervical cancer cells
Imaging of endometrial and cervical cancer
Innovations in Cervical and Endometrial Cancer
Potential new biomarkers for endometrial cancer
Methylated DNA/RNA in Body Fluids as Biomarkers for Lung Cancer
Endometrial carcinomas with ambiguous histology often harbor TP53 mutations
Identification of differentially methylated genes as diagnostic and prognostic biomarkers of breast cancer
Fertility preservation in women with cervical, endometrial or ovarian cancers
Endometrial polyps are non-neoplastic but harbor epithelial mutations in endometrial cancer drivers at low allelic frequencies
Protein biomarkers in cervicovaginal lavages for detection of endometrial cancer
Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells
JAK2 inactivating mutations promotes endometrial cancer progression by targeting HIF-1α
Effects of DNMT1 silencing on malignant phenotype and methylated gene expression in cervical cancer cells
Imaging of endometrial and cervical cancer
Innovations in Cervical and Endometrial Cancer
Potential new biomarkers for endometrial cancer
Methylated DNA/RNA in Body Fluids as Biomarkers for Lung Cancer
Endometrial carcinomas with ambiguous histology often harbor TP53 mutations
Identification of differentially methylated genes as diagnostic and prognostic biomarkers of breast cancer
Fertility preservation in women with cervical, endometrial or ovarian cancers
Endometrial polyps are non-neoplastic but harbor epithelial mutations in endometrial cancer drivers at low allelic frequencies
Protein biomarkers in cervicovaginal lavages for detection of endometrial cancer
Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells
JAK2 inactivating mutations promotes endometrial cancer progression by targeting HIF-1α